Role of herbal medicine and gut microbiota in the prevention and treatment of obesity.
Study Design
- Study Type
- Review
- Population
- Obese population (herbal medicine review)
- Intervention
- Role of herbal medicine and gut microbiota in the prevention and treatment of obesity. Various herbal medicines
- Comparator
- None
- Primary Outcome
- Gut microbiota modulation in obesity
- Effect Direction
- Positive
- Risk of Bias
- Unclear
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Obesity is a common metabolic dysfunction disease, which is highly correlated with the homeostasis of gut microbiota (GM). The dysregulation of GM on energy metabolism, immune response, insulin resistance and endogenous metabolites (e.g., short chain fatty acids and secondary bile acids) can affect the occurrence and development of obesity. Herbal medicine (HM) has particular advantages and definite therapeutic effects in the prevention and treatment of obesity, but its underlying mechanism is not fully clear. AIM OF THE STUDY: In this review, the representative basic and clinical anti-obesity studies associated with the homeostasis of GM regulated by HM including active components, single herb and herbal formulae were summarized and discussed. We aim to provide a state of art reference for the mechanism research of HM in treating obesity and the further development of new anti-obesity drugs. MATERIALS AND METHODS: The relevant information was collected by searching keywords (obesity, herbal medicine, prescriptions, mechanism, GM, short chain fatty acids, etc.) from scientific databases (CNKI, PubMed, SpringerLink, Web of Science, SciFinder, etc.). RESULTS: GM dysbiosis did occur in obese patients and mice, whiles the intervention of GM could ameliorate the condition of obesity. HM (e.g., berberine, Ephedra sinica, Rehjnannia glutinosa, and Buzhong Yiqi prescription) has been proved to possess a certain regulation on GM and an explicit effect on obesity, but the exact mechanism of HM in improving obesity by regulating GM remains superficial. CONCLUSION: GM is involved in HM against obesity, and GM can be a novel therapeutic target for treating obesity.
TL;DR
GM is involved in HM against obesity, and GM can be a novel therapeutic target for treating obesity.
Used In Evidence Reviews
Similar Papers
American journal of physiology. Endocrinology and metabolism · 2019
Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
Food & function · 2022
Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
Journal of integrative medicine · 2020
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2022
The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats.
Current pharmaceutical design · 2023
Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review.
Pharmaceuticals (Basel, Switzerland) · 2025